Strongly expressed in normal neurons, NeuN immunoreactivity is diminished under pathological conditions, such as cerebral ischemia and brain trauma [51], [52], and proposed as a biomarker to predict delayed neuronal degeneration after various brain injuries [53]. Here, RBFOX3 is linked to Cerebral ischemia.